Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice
Ge Dong, Jingjing Liu, Wenyan Jin, Hongxi Zhou, Yuchen Wen, Zhiqin Wang, Keyao Xia, Jianlin Zhang, Linxiang Ma, Yunxi Ma, Lorie Chen Cai, Qiufan Zhou, Huaquan Wang, Wei Wei, Ying Fu, Zhigang Cai
Ge Dong, Jingjing Liu, Wenyan Jin, Hongxi Zhou, Yuchen Wen, Zhiqin Wang, Keyao Xia, Jianlin Zhang, Linxiang Ma, Yunxi Ma, Lorie Chen Cai, Qiufan Zhou, Huaquan Wang, Wei Wei, Ying Fu, Zhigang Cai
View: Text | PDF
Research Article Hematology Inflammation

UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice

  • Text
  • PDF
Abstract

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a hemato-rheumatoid disease caused by somatic UBA1 mutations in hematopoietic stem cells (HSCs). The pathogenic cell type(s) responsible for the syndrome are unknown, and murine models recapitulating the disease are lacking. We report that loss of Uba1 in various mouse hematopoietic cell types resulted in pleiotropic consequences and demonstrate that an approximate 70% loss of Uba1 in neutrophils (NEs) of murine mutants induced nonlethal VEXAS-like symptoms. Depletion of Uba1 in HSCs induced extensive hematopoietic cell loss, whereas depletion of Uba1 in B cells, T cells, or megakaryocytes induced corresponding cell death, but these mutant mice appeared normal. Depletion of Uba1 in monocytes and NEs failed to induce cell death, and the mutant mice were viable. Among the tested models, only depletion of Uba1 in NEs induced autoinflammatory symptoms including increased counts and percentages of NEs, increased proinflammatory cytokines, presence of vacuoles in myeloid cells, splenomegaly, and dermatitis. Residual Uba1 was approximately 30% in the mutant NEs, which disrupted cellular hemostasis. Finally, genetic loss of the myeloid prosurvival regulator Morrbid partially mitigated the VEXAS-like symptoms. The established VEXAS-like murine model will further our understanding and treatment of the newly identified autoinflammatory syndrome prevalent among aged men.

Authors

Ge Dong, Jingjing Liu, Wenyan Jin, Hongxi Zhou, Yuchen Wen, Zhiqin Wang, Keyao Xia, Jianlin Zhang, Linxiang Ma, Yunxi Ma, Lorie Chen Cai, Qiufan Zhou, Huaquan Wang, Wei Wei, Ying Fu, Zhigang Cai

×

Figure 4

Conditional depletion of Uba1 in monocytes and macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Conditional depletion of Uba1 in monocytes and macrophages.
(A–D) Mice w...
(A–D) Mice with monocyte- and macrophage-specific loss of Uba1 remained viable and did not develop VEXAS-like symptoms. In A and B, the results are from Lyz2Cre Uba1fl/y primary male mice; in C and D, the results are from Cx3cr1Cre Uba1fl/y primary male mice. (A and C) Analysis of blood cells by the hematological analyzer. (B and D) Representative flow cytometric profiles and quantification of the flow cytometric results. Note Lyz2Cre Uba1fl/y–CKO mutants manifested a subtly increased WBC count and an increased percentage of NEs. (E) Quantification of residual Uba1 mRNA transcripts in NEs and monocytes from WT (Uba1fl/y) and Lyz2Cre-CKO (Lyz2Cre Uba1fl/y) mice by qRT-PCR. Compared with the controls, the residual average Uba1 mRNA transcript levels in mutant NEs were approximately 75%, whereas the levels in mutant monocytes were 25% in Lyz2Cre Uba1fl/y–CKO mice, suggesting that Lyz2Cre was mainly active in monocytes and with subtle leakage in NEs. n = 5 biological repeats. (F) Quantification of residual Uba1 proteins in NEs and monocytes from WT (Uba1fl/y) and Lyz2Cre-CKO (Lyz2Cre Uba1fl/y) mice by Western blotting. Upper panel, expression of Uba1 in isolated NEs. Lower panel, expression of Uba1 in isolated monocytes. Note that in the Lyz2Cre-CKO mutants, a 76% reduction of Uba1 was detected in monocytes (average residual level: 24%, P = 0.0003), with only a 21% reduction of Uba1 in NEs (average residual level: 79%, P = 0.1359). Three independent biological repeats (R1, R2, and R3) were included. Data represent the mean ± SEM. *P < 0.05 and ***P < 0.001, by Student’s t-test. n = 3~11 biological repeats. Expr., expression.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts